In response to the declaration of global pandemic of Coronavirus infectious disease 2019 (COVID-19) caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we provide comprehensive content on Coronavirus molecular structures and its interactions:
SARS-CoV-2 spike Protein TM domain
Polymer type: polypeptide(L)
Total | 1H | 13C | 15N | |
---|---|---|---|---|
All | 32.9 % (81 of 246) | 16.7 % (20 of 120) | 39.4 % (41 of 104) | 90.9 % (20 of 22) |
Backbone | 64.3 % (81 of 126) | 45.5 % (20 of 44) | 67.2 % (41 of 61) | 95.2 % (20 of 21) |
Sidechain | 0.0 % (0 of 139) | 0.0 % (0 of 76) | 0.0 % (0 of 62) | 0.0 % (0 of 1) |
Aromatic | 0.0 % (0 of 22) | 0.0 % (0 of 11) | 0.0 % (0 of 10) | 0.0 % (0 of 1) |
Methyl | 0.0 % (0 of 52) | 0.0 % (0 of 26) | 0.0 % (0 of 26) |
1. entity 1
WLGFIAGLIA IVLVTILLSS TSolvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 303 K, pH 6.8, Details 55 mM [U-99% 2H] 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine, 100 mM [U-99% 2H] 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine, 20 mM TRIS, 0.02 % sodium azide, 20 mM sodium chloride, 1 mM [U-13C; U-15N] Spike glycoprotein, 90% H2O/10% D2O
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
1 | 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine | [U-99% 2H] | 55 mM | |
2 | 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine | [U-99% 2H] | 100 mM | |
3 | TRIS | natural abundance | 20 mM | |
4 | sodium azide | natural abundance | 0.02 % | |
5 | sodium chloride | natural abundance | 20 mM | |
6 | Spike glycoprotein | [U-13C; U-15N] | 1 mM |
Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 303 K, pH 6.8, Details 55 mM [U-99% 2H] 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine, 100 mM [U-99% 2H] 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine, 20 mM TRIS, 0.02 % sodium azide, 20 mM sodium chloride, 1 mM [U-13C; U-15N; U-2H] Spike glycoprotein, 90% H2O/10% D2O
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
7 | 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine | [U-99% 2H] | 55 mM | |
8 | 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine | [U-99% 2H] | 100 mM | |
9 | TRIS | natural abundance | 20 mM | |
10 | sodium azide | natural abundance | 0.02 % | |
11 | sodium chloride | natural abundance | 20 mM | |
12 | Spike glycoprotein | [U-13C; U-15N; U-2H] | 1 mM |
Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 303 K, pH 6.8, Details 55 mM 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine, 100 mM 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine, 20 mM TRIS, 0.02 % sodium azide, 20 mM sodium chloride, 1 mM [U-15N; U-2H] Spike glycoprotein, 90% H2O/10% D2O
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
13 | 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine | natural abundance | 55 mM | |
14 | 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine | natural abundance | 100 mM | |
15 | TRIS | natural abundance | 20 mM | |
16 | sodium azide | natural abundance | 0.02 % | |
17 | sodium chloride | natural abundance | 20 mM | |
18 | Spike glycoprotein | [U-15N; U-2H] | 1 mM |
Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 303 K, pH 6.8, Details 55 mM 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine, 100 mM 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine, 20 mM TRIS, 0.02 % sodium azide, 20 mM sodium chloride, 1 mM [U-13C; U-15N; U-2H] Spike glycoprotein, 90% H2O/10% D2O
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
19 | 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine | natural abundance | 55 mM | |
20 | 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine | natural abundance | 100 mM | |
21 | TRIS | natural abundance | 20 mM | |
22 | sodium azide | natural abundance | 0.02 % | |
23 | sodium chloride | natural abundance | 20 mM | |
24 | Spike glycoprotein | [U-13C; U-15N; U-2H] | 1 mM |